Monte Carlo Simulation for the Pharmaceutical Industry
-10%
portes grátis
Monte Carlo Simulation for the Pharmaceutical Industry
Concepts, Algorithms, and Case Studies
Chang, Mark
Taylor & Francis Ltd
10/2018
564
Mole
Inglês
9781138374386
15 a 20 dias
453
Descrição não disponível.
Simulation, Simulation Everywhere. Virtual Sampling Techniques. Overview of Drug Development. Meta-Simulation for Pharmaceutical Industry. Macro-Simulation for Pharmaceutical R & D. Clinical Trial Simulation (CTS). Clinical Trial Management and Execution. Prescription Drug Commercialization. Molecular Design and Simulation. Disease Modeling and Biological Pathway Simulation. Pharmacokinetic Simulation. Pharmacodynamic Simulation. Monte Carlo for Inference and Beyond. Appendices. Afterword. Bibliography.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Interim Analysis;Sample Size Re-estimation;adaptive;Markov Decision Process;design;Plasma Concentration;algorithm;PN;clinical;MC;trial;PBPK Model;drug;MC Algorithm;development;Conditional Power;backward;Stopping Boundaries;induction;GA;markov;Sample Size Reestimation;Drug Concentration;Cellular Automata;HPN;Reachability Graph;Adaptive Design;Versus;Error Spending Function;Nash Equilibrium;PSA Decline;PSA Reduction;Free DM1;Compulsory Licensing;International Exhaustion
Simulation, Simulation Everywhere. Virtual Sampling Techniques. Overview of Drug Development. Meta-Simulation for Pharmaceutical Industry. Macro-Simulation for Pharmaceutical R & D. Clinical Trial Simulation (CTS). Clinical Trial Management and Execution. Prescription Drug Commercialization. Molecular Design and Simulation. Disease Modeling and Biological Pathway Simulation. Pharmacokinetic Simulation. Pharmacodynamic Simulation. Monte Carlo for Inference and Beyond. Appendices. Afterword. Bibliography.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Interim Analysis;Sample Size Re-estimation;adaptive;Markov Decision Process;design;Plasma Concentration;algorithm;PN;clinical;MC;trial;PBPK Model;drug;MC Algorithm;development;Conditional Power;backward;Stopping Boundaries;induction;GA;markov;Sample Size Reestimation;Drug Concentration;Cellular Automata;HPN;Reachability Graph;Adaptive Design;Versus;Error Spending Function;Nash Equilibrium;PSA Decline;PSA Reduction;Free DM1;Compulsory Licensing;International Exhaustion
